Scientific article
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
ContributorsVermunt, Lisa; Sikkes, Sietske A M; van den Hout, Ardo; Handels, Ron; Bos, Isabelle; van der Flier, Wiesje M; Kern, Silke; Ousset, Pierre-Jean; Maruff, Paul; Skoog, Ingmar; Verhey, Frans R J; Freund-Levi, Yvonne; Tsolaki, Magda; Wallin, Åsa K; Olde Rikkert, Marcel; Soininen, Hilkka; Spiru, Luisa; Zetterberg, Henrik; Blennow, Kaj; Scheltens, Philip; Muniz-Terrera, Graciela; Visser, Pieter Jelle; Alzheimer's Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups
CollaboratorsZekry Berger, Dina Selma
Published inAlzheimer's & Dementia, vol. 15, no. 7, p. 888-898
Publication date2019
Abstract
Keywords
- Aged
- Alleles
- Alzheimer Disease/genetics/pathology
- Amyloid
- Apolipoprotein E4/genetics
- Biomarkers/cerebrospinal fluid
- Cognitive Dysfunction/pathology
- Disease Progression
- Female
- Genotype
- Humans
- Longitudinal Studies
- Male
- Positron-Emission Tomography
- Prodromal Symptoms
- Sex Factors
- Time Factors
- tau Proteins/cerebrospinal fluid
Affiliation entities
Citation (ISO format)
VERMUNT, Lisa et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer’s disease in relation to age, sex, and APOE genotype. In: Alzheimer’s & Dementia, 2019, vol. 15, n° 7, p. 888–898. doi: 10.1016/j.jalz.2019.04.001
Main files (1)
Article (Accepted version)
Identifiers
- PID : unige:146823
- DOI : 10.1016/j.jalz.2019.04.001
- PMID : 31164314
Journal ISSN1552-5260
